# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318154-24-000011
Filing Date
2024-02-14
Accepted
2024-02-14 16:23:32
Documents
172
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | amgn-20231231.htm iXBRL | 10-K | 3754954
2 | DESCRIPTION OF SECURITIES | exhibit433-descriptionofse.htm | EX-4.33 | 232230
3 | FORM OF GRANT OF STOCK OPTION AGREEMENT | exhibit102-formofgrantofst.htm | EX-10.2 | 270222
4 | FORM OF RESTRICTED STOCK UNIT AGREEMENT | exhibit103-formofrestricte.htm | EX-10.3 | 275058
5 | FORM OF PERFORMANCE UNIT AGREEMENT | exhibit105-formofperforman.htm | EX-10.5 | 257439
6 | AMGEN INC. 2009 DIRECTOR EQUITY INCENTIVE PROGRAM | exhibit106-2009directorequ.htm | EX-10.6 | 50851
7 | FIFTH AMENDMENT TO SUPPLEMENTAL RETIREMENT PLAN | exhibit1095-fifthamendment.htm | EX-10.9 5 | 5680
8 | FOURTH AMENDMENT TO NONQUALIFIED DEFERRED COMPENSATION PLAN | exhibit10124-fourthamendme.htm | EX-10.12 4 | 4535
9 | AGREEMENT BETWEEN AMGEN INC. AND JAMES BRADNER | exhibit1014-agreementbetwe.htm | EX-10.14 | 73583
10 | COLLABORATION AND LICENSE AGREEMENT BETWEEN AMGEN INC. AND CELLTECH R&D LIMITED | exhibit1017-collaborationa.htm | EX-10.17 | 1782514
11 | AMENDMENT NO 2 TO CELLTECH COLLABORATION AND LICENSE AGREEMENT | exhibit10171-amendmentno2t.htm | EX-10.17 1 | 31614
12 | LETTER AGREEMENT RE FTE RATES | exhibit10225-letteragreeme.htm | EX-10.22 5 | 14986
13 | SUBSIDIARIES OF THE COMPANY | amgn-ex21_2023.htm | EX-21 | 30192
14 | RULE 13A-14(A) CERTIFICATIONS | amgn-ex31_20231231x10k.htm | EX-31 | 19856
15 | SECTION 1350 CERTIFICATIONS | amgn-ex32_20231231x10k.htm | EX-32 | 9555
16 | POLICY ON RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION | exhibit97-policyonrecovery.htm | EX-97 | 23391
22 | GRAPHIC | amgenlogo.jpg | GRAPHIC | 47602
23 | GRAPHIC | amgenlogo1.jpg | GRAPHIC | 47602
24 | GRAPHIC | amgenlogoa.jpg | GRAPHIC | 47602
25 | GRAPHIC | amgn-20231231_g1.jpg | GRAPHIC | 167843
26 | GRAPHIC | amgn-20231231_g2.jpg | GRAPHIC | 179905
27 | GRAPHIC | image_011a.jpg | GRAPHIC | 31874
28 | GRAPHIC | image_012a.jpg | GRAPHIC | 31874
29 | GRAPHIC | image_01a.jpg | GRAPHIC | 31874
30 | GRAPHIC | image_1a.jpg | GRAPHIC | 9930
| Complete submission text file | 0000318154-24-000011.txt |  | 23081937

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
17 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | amgn-20231231.xsd | EX-101.SCH | 118693
18 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | amgn-20231231_cal.xml | EX-101.CAL | 139860
19 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | amgn-20231231_def.xml | EX-101.DEF | 776114
20 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | amgn-20231231_lab.xml | EX-101.LAB | 1363434
21 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | amgn-20231231_pre.xml | EX-101.PRE | 1078335
173 | EXTRACTED XBRL INSTANCE DOCUMENT | amgn-20231231_htm.xml | XML | 3089943

Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37702 | Film No.: 24638830
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)